Our Mission
Empower embryologists to dramatically improve IVF success rates by improving sperm cell selectionTo do so, QART Medical has developed a breakthrough solution for characterizing and selecting sperm cells.
QART Medical (read: Q – Art) is addressing the quiet global pandemic: infertility. As fertile sperm cells are in decline, in-vitro fertilization (IVF) has become a near ubiquitous solution. However, the process of selecting sperm cells for IVF is limited by the transparent nature of sperm cells, making it difficult for an embryologist to select the best cells to use.
QART (Quantitative Assisted Reproductive Technologies) has developed a breakthrough solution for the highly informative characterization and selection of sperm cells. We aim to create a new and improved gold standard in the ART market to improve the success rates of IVF procedures by:
1. Quantitatively characterizing the morphology and contents of individual sperm cells with 3D topographic imaging.
2. Using machine imaging to automatically compare individual sperm cells to objective consensus criteria in real-time.
3. Providing quantitative information on DNA integrity on a cell-by-cell basis.
The Team
Alon Shalev, MSc
Co-Founder, CEOin
Alon Shalev, QART’s co-founder and CEO, brings his vast business and development experience in the medical device field.
22 years of experience as an Inventor, Technologist, Entrepreneur, and Executive in the MedTech sector including: Co-Founder and COO of BrainsGate (2000-2004), CEO of Nicast (2005-2007), Co-Founder and CEO of Endospan (2008-2017), Co-Founder and Executive Board Member of SynCath Neuroscience (2018-Present). MSc (cum laude) in Electrical Engineering from Tel-Aviv University.
Prof. Natan T. Shaked, PhD
Co-Founder, Chief Scientific Officerin
Natan Shaked - QART’s co-founder and chief scientist, brings his immense research experience and know- how as well as his expertise with holographic imaging of sperm cells.
Natan has been an active researcher for over 18 years. Chair of Biomedical Engineering Department at Tel Aviv University, Israel. Visiting Assistant Professor in the Department of Biomedical Engineering at Duke University. Chair of the SPIE Label-Free Biomedical Imaging and Sensing (LBIS) Annual Conference in San Francisco. Fellow of the Optical Society of America (OSA). Author of over 90 peer-reviewed journal papers, over 160 conference papers, and chapters in several books.
Shimon Oz, MBA
Chief Financial Officerin
Shimon Oz, QART’s CFO, brings over 25 years of extensive financial and business management experience.
Shimon has served as a CFO, executive director, economic consultant, independent advisor, and investment banker for clients including Scitex Corp, Forum Film, Elan Jaglom Group, Mig Group, Infinity VC Group, Dekora Group and others. Shimon holds an MA in economics and an MBA (cum laude) from The Hebrew University of Jerusalem.
Arik Drori, MBA
VP R&Din
Arik Drori, QART’s VP R&D, brings over 20 years’ experience in R&D with well-developed leadership and problem-solving skills. Arik is an innovator with out-of-the-box way of thinking.
Arik led system & development teams in Real-imaging, GE-Versamed, Optical-imaging, and more. Arik holds a BSc in electrical engineering from Tel-Aviv University, and MBA from Heriot-watt university in Scotland.
Noa Siegel
Clinical, Regulatory, and QA AffiliateNoa, QART's Clinical, Regulatory, and QA Affiliate, provides support in the execution of clinical trials, regulatory submissions, and quality system operations. She is currently pursuing a degree in Biomedical sciences with a specialization in Neuroscience at the Hebrew University of Jerusalem and brings operational experience and expertise from service in the Israel Defense Forces.
Yirmiyahu Tesler
Software Team LeaderYirmiyahu Tesler, QART’s Software Team Leader, brings strong expertise in software development and team management.
Yirmiyahu has led multiple engineering teams, and specializes in building scalable systems and driving complex projects from concept to deployment.
Dana Goldkorn
Algorithm engineerin
Dana Goldkorn, QART’s SW and Algorithm engineer brings exceptional programming know-how and experience with holographic imaging.
Dana is finalizing her M.Sc in electrical engineering from Tel-Aviv university, developing image processing algorithms for holographic imaging.
Simcha K. Mirsky, PhD
Optics Design LeaderSimcha Mirsky, QART’s Optics Design Leader, has a PhD in biomedical engineering from Tel Aviv University and brings over 9 years of experience in holographic system design and image processing, with 22 peer-reviewed papers and 2 patents in this field.
Scientific Panel
Dr. Robert Wah, MD
Former President of American Medical Association (AMA). Former Global Chief Medical Officer @CSC (now DXC) for 12 Years. Served in the US Navy for 23 years including as Associate CIO for the Military Health System where he managed >$900M in annual Health IT spending at 520 hospitals covering 10M patients worldwide.
Professor Mitchell Rosen MD
in
An expert in reproductive endocrinology and fertility, serves as the Director of the UCSF Fertility Preservation Program, UCSF Health, San Francisco, USA
Dr. Susan Alpert, MD, PhD
in
Dr. Alpert acted as senior vice president and chief regulatory officer at Medtronic. Before that, Dr. Alpert was the Vice President of Regulatory Sciences at C.R. Bard. Dr. Alpert held multiple positions at the FDA including as director of the FDA’s Office of Device Evaluation. Dr. Alpert holds an MD from the University of Miami (Florida) and a Ph.D. from New York University.
Professor Tomer Avidor-Reiss, Ph.D.
University of Toledo, Ohio, USA. Studies subcellular organelles including the centriole, centrosome, and cilium; how they are formed, function, and are involved with infertility
Eliezer Girsh, PhD
in
Dr. Girsch is a senior biologist and embryologist with years of experience in working with sperm and ova. He is a clinical embryologist and andrologist and manager of the sperm lab and bank at Barzilay Medical Center.